Biogen Inc
-
Business
Eli Lilly says FDA delays approval of Alzheimer’s drug in surprise move
[ad_1] Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in…
Read More » -
Health News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
[ad_1] A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen on Tuesday reported fourth-quarter revenue and profit that…
Read More » -
Pics News
The S&P 500 will try to maintain its momentum next week after breaching 5,000, with key inflation data, earnings on deck
[ad_1] The S & P 500 broke past 5,000 for the first time ever this week, but investors will see…
Read More » -
Health News
‘A trove of rebound opportunities’: Strategists turn bullish on biotech and more, picking top stocks
[ad_1] 2023 wasn’t a good year for the health-care sector, but some investors expect it to make a comeback this…
Read More » -
Health News
Obesity and Alzheimer’s drugs pack one-two punch to power Eli Lilly higher in 2024
[ad_1] Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual…
Read More » -
Health News
Weight loss drugs, Alzheimer’s treatments and gene editing: Enormous firsts defined 2023 in pharma
[ad_1] Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts…
Read More » -
Health News
If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
[ad_1] Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk…
Read More » -
Health News
More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study
[ad_1] Eisai on Wednesday said an injectable version of the Alzheimer’s drug Leqembi showed promising initial results in a clinical…
Read More » -
Pics News
Sage Therapeutics stock plunges more than 50% after FDA decision on postpartum depression drug
[ad_1] In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a smartphone and on a…
Read More » -
Health News
These health-care companies see opportunity ahead from Alzheimer’s drug approval
[ad_1] As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs, blood tests and other…
Read More »